-
Pharmacology
-
- - Enzymes
-
- ATPase & GTPase
- Carboxylase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Hydroxylase
- Isomerase
- - Kinase
-
- Adenosine kinase
- Akt
- AMP-kinase
- ATM
- Aurora
- CAM Kinase
- Casein kinase
- Chk
- Cyclin-dependent kinase
- DNA-dependent Protein Kinase
- DYRK
- FAK
- General
- Glycogen synthase kinase
- JAK
- MAPK
- mTOR
- Myosin light chain kinase
- PAK
- PI3-kinase
- PIKfyve
- PLK
- Protein Kinase A
- Protein Kinase C
- Protein Kinase G
- Rho kinase
- Sphingosine kinase
- Src
- Tyrosine Kinase
- Ligase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase & Transcriptase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Leukotriene & Related
- Lysophospholipid receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- Orphan 7-TM Receptors
- Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- CRF
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Platelet-Activating Factor (PAF)
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 169 products in: Biochemicals >> Pharmacology >> Enzymes >> Kinase
Kinase beginning with A - G |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| AMP-activated protein kinase activator Purity: > 99% |   | ||
| Potent, selective and cell-permeable VEGFR inhibitor Purity: > 98% |  | ||
| Second messenger. PKA activator. Purity: > 98% | | ||
| Selective PDGFR tyrosine kinase inhibitor Purity: > 99% | | ||
| Potent, selective EGF receptor tyrosine kinase Purity: > 99% | | ||
| Potent specific PDGF receptor tyrosine kinase inhibitor Purity: > 99% | | ||
| Selective EGF receptor tyrosine kinase inhibitor Purity: > 98% | | ||
| JAK2/3 inhibitor Purity: > 99% | | ||
| Cell-permeable activator of AMP-activated protein kinase Purity: > 98% |  | ||
| Potent isozyme selective Akt1/2 kinase inhibitor Purity: > 97% | | ||
| Protein synthesis inhibitor Purity: > 98% | | ||
| Highly selective GSK-3 inhibitor Purity: > 99% | | ||
| Potent and selective PI3Kγ inhibitor Purity: > 98% | | ||
| Potent and selective PI3Kγ inhibitor Purity: > 95% | | ||
| Selective, ATP-competitive PI3Kγ inhibitor Purity: > 98% | | ||
| Potent and selective PI3Kγ inhibitor Purity: > 98% | | ||
| Novel, potent and selective JAK2 inhibitor Purity: > 95% | | ||
| Potent, selective, cell-permeable Syk kinase inhibitor Purity: > 98% | | ||
| Potent, irreversible ATP-competitive ErbB inhibitor. Antitumor. Purity: > 99% | | ||
| Cell-permeable, ATP-competitive 7 Arabidopsis GSK-3 inhibitor Purity: > 95% | | ||
| Potent Cdk5/p25 and Cdk2 inhibitor Purity: > 98% | | ||
| Selective HER1 and HER2 inhibitor Purity: > 99% | | ||
| Cell permeable, selective, ATP-competitive cyclin-dependent kinase (CDK) inhibitor Purity: > 99% | | ||
| Potent irreversible EGFR and HER2/ErbB2 tyrosine kinase inhibitor Purity: > 99% | | ||
| CK2 inhibitor Purity: > 95% | | ||
| Selective, ATP competitive CK2 inhibitor Purity: > 95% | | ||
| Anti-inflammatory and anti-proliferative agent Purity: > 99% | | ||
| MNK inhibitor Purity: > 98% | | ||
| Apoptosis inducer. Protein kinase C inhibitor. Purity: > 99% | | ||
| 8-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate (8-CPT-cAMP) | Cell permeable cAMP analogue, protein kinase modulator Purity: > 98% | | |
| ATP non-competitive MEK1/2 inhibitor Purity: > 95% | | ||
| Potent, selective HER2/ErbB2 tyrosine kinase inhibitor Purity: > 95% | | ||
| Akt peptide substrate Purity: > 98% | | ||
| Akt peptide substrate, biotinylated Purity: > 98% | | ||
| Potent, selective ATP-competitive casein kinase 2 inhibitor Purity: > 95% | | ||
| CK1 inhibitor Purity: > 99% | | ||
| Protein kinase inhibitor. Anti-tumor. Purity: > 99% | | ||
| Akt inhibitor. Anti-cancer agent. Purity: > 98% | | ||
| Potent and selective PDGFRβ inhibitor Purity: > 99% | | ||
| Casein kinase II inhibitor Purity: > 98% | | ||
| Selective, cell-permeable calmodulin (CaM) antagonist Purity: > 98% | | ||
| Selective, casein kinase 2 (CK2) inhibitor Purity: > 99% | | ||
| Potent anti-oxidant flavonoid Purity: > 98% | | ||
| EGFR tyrosine kinase inhibitor Purity: > 98% | | ||
| Potent HER-1/EGFR tyrosine kinase inhibitor Purity: > 98% | | ||
| Potent mTOR inhibitor Purity: > 98% | | ||
| Stable, potent PKC activator Purity: > 98% | | ||
| Potent, non-selective PI3K inhibitor Purity: > 95% | | ||
| Protein tyrosine kinase inhibitor. Anticancer agent. Purity: > 99% | | ||
| Isoflavone glycoside; inactive analog of Genistein Purity: > 99% | | ||
| Potent, cell permeable, ATP-competitive PKC inhibitor Purity: > 99% | | ||
| Potent PKC inhibitor. Selective for PKCα and β Purity: > 99% | |